National and Kapodistrian University of Athens
Η επίδραση της ορμονικής θεραπείας και της τιβολόνης στον αθηρωματογόνο χημειοτακτισμό των λευκών αιμοσφαιρίων του περιφερικού αίματος
Abstract
dc:descriptionThe cardinal role of chronic inflammation in the development of atherosclerosis is increasingly being recognized. Estrogens may prevent the evolution of atherosclerosis by suppressing immune response. Furthermore, the conflicting reports on the cardiovascular effects of hormone therapy between observational and clinical trials have triggered interest on the effect of alternative therapies on the cardiovascular system. The main aim of this study was to assess the effect of estrogen therapy, low-dose estrogen - progestin theapy and tibolone on circulating markers of chemotaxis in healthy postmenopausal women, such as the chemotactic factors MCP-1 and RANTES. An other goal of the present study has been to investigate the possible association between the above mentioned chemokines and the lipid and hormonal profile of healthy menopausal women. According to the results of this study, MCP-1 and RANTES plasma levels were found decreased after treatment with CEE and E2/NETA respectively, while tibolone had no effect on these chemokines. These findings could possibly correlate hormone therapy with an additional cardioprotective mechanism by inhibiting the expression of chemoattractant molecules and, thus, attenuating inflammation. Secondly, in the present study, no association has emerged between the above mentioned chemokines and the lipid profile. Regarding the hormonal profile, endogenous testosterone and free androgen index (FAI) were found to correlate negatively with serum RANTES, as opposed to SHBG which correlated positively with serum RANTES. These results imply that endogenous androgens may suppress the chemotactic response. The relevance of these findings in terms of clinically established caridoprotection remains to be clarified.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vlachou, Sofia
- Βλάχου, Σοφία
Subjects
dc:subject × 20- Ορμονική θεραπεία
- Τιβολόνη
- Εμμηνόπαυση
- Καρδιαγγειακό σύστημα
- Αθηροσκλήρυνση
- Χημειοτακτισμός
- Παράγοντας MCD-1
- Παράγοντας Rantes
- Hormone therapy
- Tibolone
- Postmenopausal
- Cardiovascular
- Atherosclerosis
- Chemotactic factors
- MCP-1
- Rantes
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24044